Evidence map›Paper›PMID 23232694›Full record

ArticleEuropean journal of human genetics : EJHG2013

Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum.

Xiaolong Zhou, Sikandar G Khan, Deborah Tamura, Takahiro Ueda, Jennifer Boyle, Emmanuel Compe, Jean-Marc Egly, John J DiGiovanna, Kenneth H Kraemer

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Assessment of the variant prioritization strategy for genomic newborn screening in the Generation Study.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. TFIIH-dependent MMP-1 overexpression in trichothiodystrophy leads to extracellular matrix alterations in patient skin.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Xiaolong ZhouDNA Repair Section, Dermatology Branch, Center for Cancer Research, National Cancer Institute/NIH, Bethesda, MD 20892, USA.
Sikandar G Khan
Deborah Tamura
Takahiro Ueda
Jennifer Boyle
Emmanuel Compe
Jean-Marc Egly
John J DiGiovanna
Kenneth H Kraemer
National Cancer Institute · USCenter for Cancer Research · USInstitut de Recherche contre les Cancers de l’Appareil Digestif · FR

Funding

DNA Repair in Human Cancer-Prone Genetic DiseasesZIABC004517 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KRAEMER, KENNETH H · 2009 to 2024
$26.5M
Intramural NIH HHS
6 · The paper itself

Abstract

XPD (ERCC2) is a DNA helicase involved in nucleotide excision repair and in transcription as a structural bridge tying the transcription factor IIH (TFIIH) core with the cdk-activating kinase complex, which phosphorylates nuclear receptors. Mutations in XPD are associated with several different phenotypes, including trichothiodystrophy (TTD), with sulfur-deficient brittle hair, bone defects, and developmental abnormalities without skin cancer, xeroderma pigmentosum (XP), with pigmentary abnormalities and increased skin cancer, or XP/TTD with combined features, including skin cancer. We describe the varied clinical features and mutations in nine patients examined at the National Institutes of Health who were compound heterozygotes for XPD mutations but had different clinical phenotypes: four TTD, three XP, and two combined XP/TTD. We studied TFIIH-dependent transactivation by nuclear receptor for vitamin D (VDR) and thyroid in cells from these patients. The vitamin D stimulation ratio of CYP24 and osteopontin was associated with specific pairs of mutations (reduced in 5, elevated in 1) but not correlated with distinct clinical phenotypes. Thyroid receptor stimulation ratio for KLF9 was not significantly different from normal. XPD mutations frequently were associated with abnormal VDR stimulation in compound heterozygote patients with TTD, XP, or XP/TTD.

Indexed as

MutationAdolescentAdultCells, CulturedChildCholecalciferolDNA RepairFemaleFibroblastsGene ExpressionHumansKruppel-Like Transcription FactorsMaleOsteopontinReceptors, CalcitriolReceptors, Cytoplasmic and NuclearCholecalciferolERCC2 protein, humanKLF9 protein, humanKruppel-Like Transcription FactorsOsteopontinReceptors, CalcitriolReceptors, Cytoplasmic and NuclearSteroid HydroxylasesTranscription Factor TFIIHTriiodothyronineVitamin D3 24-HydroxylaseVitaminsXeroderma Pigmentosum Group D Protein

Identifiers

PMID23232694
PMCPMC3722669
OpenAlexW2011548935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.